Carregando...
2119. Matched-Paired Analysis of Patients Treated for Invasive Mucormycosis—Standard Treatment vs. Posaconazole New Formulations (MoveOn)
BACKGROUND: Current first-line (first) antifungal treatment for invasive mucormycosis (IM) consists of liposomal amphotericin B (AMB). Salvage (SAL) treatment options are limited and often based on posaconazole oral suspension (POSsusp). However, with the approval of posaconazole new formulations (P...
Na minha lista:
| Publicado no: | Open Forum Infect Dis |
|---|---|
| Principais autores: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6809098/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1799 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|